In a cohort of individuals with respiratory symptoms, 21% had undiagnosed COPD or asthma. Researchers found poorer outcomes in the undiagnosed cohorts vs. healthy controls. Perspective from Andrew J.

Please provide your email address to receive an email when new articles are posted on . Tezepelumab has received an FDA breakthrough therapy designation as a maintenance treatment for patients ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...